Skip to content
drillr.ai
Sign up

ONC

BeOne Medicines Ltd.

NASDAQ · Healthcare · Medical - Pharmaceuticals · US

Also listed · 06160.HK →688235.SH →BGNE →
$350.84
−0.74%
Ask drillr
0
Insider buys (3m)
105
Insider sells (3m)
-$311.0M
Net value (3m)
+28.6%
Price return (3m)
Form 4 filings
DateInsiderActivitySharesPrice
Sep 10, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale10,688$349
Sep 10, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale1,721$348
Sep 10, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale2,841$346
Sep 10, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdM-Exempt403,351$2.84
Sep 10, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale1,517$347
Sep 10, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale6,278$351
Sep 10, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale7,492$348
Sep 10, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale1,181$345
Sep 10, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdM-Exempt31,027$37
Sep 10, 2026Wang Xiaodong · director, other: Chair, Scientific Advisory BrdSale6,569$350
Sep 3, 2026Ball Titus B. · officer: Principal Accounting OfficerSale132$356
Aug 27, 2026Wu Xiaobin · officer: President and COOSale280$380
Aug 13, 2026Lee Chan Henry · officer: SVP, General CounselM-Exempt13,754$16
Aug 13, 2026Lee Chan Henry · officer: SVP, General CounselM-Exempt796$159
Aug 13, 2026Lee Chan Henry · officer: SVP, General CounselSale2,666$360
Aug 13, 2026Lee Chan Henry · officer: SVP, General CounselM-Exempt1,058$213
Aug 13, 2026Lee Chan Henry · officer: SVP, General CounselM-Exempt10,556$15
Aug 13, 2026Lee Chan Henry · officer: SVP, General CounselM-Exempt812$194
Aug 13, 2026Lee Chan Henry · officer: SVP, General CounselM-Exempt10,348$12
Aug 12, 2026OYLER JOHN · director, officer: Chief Executive OfficerSale20,899$358
Aug 12, 2026OYLER JOHN · director, officer: Chief Executive OfficerSale1,200$366
Aug 12, 2026OYLER JOHN · director, officer: Chief Executive OfficerSale6,717$355
Aug 12, 2026OYLER JOHN · director, officer: Chief Executive OfficerSale12,418$357
Aug 12, 2026OYLER JOHN · director, officer: Chief Executive OfficerSale67$350
Aug 12, 2026OYLER JOHN · director, officer: Chief Executive OfficerSale14,102$359
Aug 12, 2026OYLER JOHN · director, officer: Chief Executive OfficerSale3,673$353
Aug 12, 2026OYLER JOHN · director, officer: Chief Executive OfficerSale11,568$362
Aug 12, 2026OYLER JOHN · director, officer: Chief Executive OfficerSale14,569$361
Aug 12, 2026OYLER JOHN · director, officer: Chief Executive OfficerSale13,695$359
Aug 12, 2026OYLER JOHN · director, officer: Chief Executive OfficerSale2,813$352
Institutional positioning

13F filings over the trailing two quarters

New 83Increased 218Reduced 177Sold out 51
FilerActionSharesFiled
BAKER BROS. ADVISORS LPIncreased8,801,567Aug 14, 2026
BAKER BROS. ADVISORS LPUnchanged8,799,053May 15, 2026
PRIMECAP MANAGEMENT CO/CA/Increased5,007,931Aug 14, 2026
PRIMECAP MANAGEMENT CO/CA/Reduced4,975,181May 11, 2026
Capital International InvestorsIncreased4,210,221Aug 12, 2026
CAPITAL INTERNATIONAL INVESTORSReduced4,158,726May 13, 2026
FMR LLCReduced3,693,610May 15, 2026
FMR LLCReduced2,478,527Aug 13, 2026
Capital World InvestorsIncreased2,249,582Aug 12, 2026
CAPITAL WORLD INVESTORSNew Position1,622,687May 13, 2026
CITADEL ADVISORS LLCIncreased1,445,817Sep 2, 2026
CITADEL ADVISORS LLCIncreased1,052,498May 15, 2026
HHLR ADVISORS, LTD.Unchanged1,034,306May 15, 2026
TEMASEK HOLDINGS (PRIVATE) LTDReduced862,643May 12, 2026
Temasek Holdings (Private) LtdReduced845,729Aug 7, 2026

Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Sep 10, 2026